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INTRODUCTION
Non-healing and chronic wounds are a significant 
healthcare problem in today’s medical practice.[1] Wound 
healing is the process of restoration of physical integrity of 
internal or external body structures and involves complex 
interactions between the cells and various other factors.[2] 
The healing process consists of a sequence of overlapping 
events including inflammatory responses, regeneration 
of the epidermis, shrinkage of the wound and finally 
connective tissue formation, and remodeling.  [2] Appropriate 
treatment and wound care accelerate the healing process 
and prevent infection and chronicity of the wound.[3] 
Different methods and approaches have been used to 
achieve shorter wound healing times.[1] Despite extensive 
efforts to improve wound healing, the outcomes of existing 
methods are far from optimal.[2]
One such agent that has been tried in wound healing is 
phenytoin. Phenytoin (diphenylhydantoin) was introduced 
into therapy in 1937 for the effective control of convulsive 
disorders.[4] A common side effect with phenytoin is the 
development of fibrous overgrowth of gingiva.[5] This 
apparent stimulatory effect of phenytoin on connective 
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tissue suggested an exciting possibility for its use in wound 
healing.[3]
Previous clinical studies have shown topical phenytoin to 
promote healing of ulcers but the efficacy of phenytoin 
in treatment of such conditions is still controversial and 
many of the existing clinical studies have methodological 
flaws, such as inappropriate statistical analysis, inadequate 
control groups, and the absence of randomization and 
double-blinding.[6] The present literature available indicates 
that topical phenytoin deserves further investigation as a 
wound healing agent in preclinical studies in a controlled 
environment.[3] Hence, this study was conducted to evaluate 
the effect of phenytoin on the wound healing process on 
laboratory rats.
MATERIALS AND METHODS
The experiment was conducted on 20 male wistar rats 
weighing 200-300 g. The animals were caged individually in 
a controlled environment (temperature 30oC) with a 12 h 
artificial light cycle. Food and water were available ad libitum 
to the rats. For carrying out the experiment, Institutional 
Animal Ethics Committee permission was taken.
Prior to creating excisional wounds the rats were anesthetized 
by intraperitoneal injection of ketamine (50 mg/kg).[2] Then 
the animals were shaved on the back and the skin was 
disinfected using cotton and alcohol wipes. Using sterile 
surgical instruments round full thickness skin wounds 
measuring 500 mm2 were created in the paravertebral 
area, 1.5 mm from midline on the back of rats, and then 
thoroughly disinfected using povidone iodine.[2,3]
All the 20 rats were then randomly allocated to two groups, 
each group containing ten rats each, namely control (Group A) 
and phenytoin treatment (Group B). For the preparation of 
1% phenytoin cream, 1 g of phenytoin powder was added to 
99 g of cold cream and it was then applied over the wound 
surface of Group B rats twice daily.[7] Control Group A 
received no drug treatment. The applications of phenytoin 
continued for 16 days from the start of the experiment.
To measure the contracture of the wound, a transparent 
plastic paper was placed on the location of wound and its 
shape was drawn on the same paper with a marker and then 
matched with the graph paper for finding the area of the 
wound (expressed in mm2).[2,8]
Wound healing was measured on Days 4, 8, 12 and 16 of the 
experiment.[3] Percentage of wound healing was calculated 
according to the Walker formula.[7]
Percentage of wound area 5 Wound area on day X/ 
Wound area on day 1 3 100 
Percentage of wound healing 5 1002Percentage of 
wound area 
The total number of days required for complete 
epithelization of the wound was noted in each rat in both 
the groups (e.g. fall of scab without any raw area).[2,8]
Statistical analysis
Data were analyzed using SPSS version 13.All the results 
were expressed as Mean 6 S.D. “Unpaired t-test” was used 
to compare area of wound healing in both the groups 
(A and B) on Days 4, 8, 12, and 16 of the experiment. 
“Unpaired t-test” was used to compare time required for 
complete epithelization of the wound in between the 
groups. P , 0.05 was considered to be significant.
RESULTS
Average area of the wound measured in sq mm 
expressed as Mean 6 S.D
The observations of the study showed that when 
average wound area was compared between Group A 
(474 6 12.07, 379 6 21.02, 293 6 18.43, 194.80 6 11.62) 
and Group B (386 6 69.31, 300 6 11.51, 221.40 6 15.23, 
113.20 6 12.24) on Days 4, 8, 12 and 16, respectively, the 
results were statistically significant (P  , 0.05) [Table 1].
Days required for complete epithelization
The observation of the study also revealed that 
the average number of days required for complete 
epithelization of wound in Group A rats (23.00 6 2.26) 
was significantly higher than the period required for 
complete epithelization in Group B rats (20.60 6 1.51) 
and the difference was statistically significant (P  , 0.05) 
[Table 2].
Table 1: Average wound measurements in the groups
Groups (n 5 10) Day 4 Day 8 Day 12 Day 16
Group A 
Wound area (mm2)
474 6
12.07
379 6
21.02
293 6
18.43
194.80 6
11.62
Group B 
Wound area (mm2)
386 6
69.31
300 6
11.51
221.40 6
15.23
113.20 6
12.24
t value 3.7669 10.4396 9.4722 15.2904
P value ,0.0017* ,0.0001* ,0.0001* ,0.0001*
When the average area of the wound measured in sq mm expressed as mean 6 S.D 
was compared between the group A and group B, it was highly statistically 
significant on Day 4, Day 8, Day 12 and Day 16 of the experiment. (*Statistically 
significant)J Young Pharm Vol 2 / No 1  61
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DISCUSSION
In 1939, Kimball first observed that gingival hyperplasia 
occurred in some patients treated with phenytoin. This 
stimulated the study regarding the potential use of 
phenytoin in wound healing.[9] Shapiro carried out the 
first clinical trial in 1958 and found out that periodontal 
patients with surgical wounds who were pretreated with oral 
phenytoin had less inflammation, less pain, and accelerated 
healing as compared to controls.[10] Subsequently, it was 
seen that phenytoin promoted the healing of dental 
extraction sockets and also increased the tensile strength 
of skin wounds.[11,12] There are studies and case reports 
about the use of topical phenytoin for a wide variety of 
soft tissue infections and ulcers.[6]
Menezes et al., Bogaert et al., and Bansal and Mukul showed 
the usefulness of topical phenytoin in lepromatous trophic 
ulcers.[13-15] El Zayat examined the effects of topical 
phenytoin on decubitus ulcers and missile wound injuries 
and found it to be useful.[16] Phenytoin showed positive 
results in the treatment of gluteal abscesses secondary to 
intramuscular injection in a study conducted by Lodha 
et al.  [17] Pendse et al. found antibacterial activity of phenytoin 
in the wound healing process.[18]
The mechanism by which phenytoin accelerates the wound 
healing process is unknown. Clinical studies suggest that 
stimulation of fibroblastic proliferation, enhancing the 
formation of granulation tissue, decreasing collagenase 
activity (by reducing its production or secretion or both), 
promoting deposition of collagen and other connective 
tissue components, decreasing bacterial contamination, 
and by decreasing the formation of wound exudate to be 
some of the ways by which topical phenytoin hastens the 
healing process.[3,19,20] Biopsies of phenytoin-treated open 
wounds show neovascularization and collagenization.[19] 
Local pain relief due to membrane-stabilizing action of 
topical phenytoin therapy has been observed in several 
studies.[20,21]
Topical application of phenytoin results in direct access 
of the drug to the target site and avoids the risk of 
getting systemic side effects.[21] The findings of the above-
mentioned study were taken into consideration for selecting 
the route of administration of phenytoin for wound healing 
in the present study.
Even with all the positive data available, the role of topical 
phenytoin in the wound healing process is still controversial 
and efficacy is doubted due to the lack of multicentric, 
double blind nature of the earlier studies. The use of topical 
phenytoin for wound healing is not approved by the USA 
Food and Drug Administration (FDA) at present.[3] In a 
paper published by FDA on orphan products development 
(1984), phenytoin was listed as an important agent for 
wound healing, subject to confirmation by fresh preclinical, 
and multicentric double blind clinical studies.[4]
In the present study, it is seen that phenytoin hastens the 
healing of excisional wound in albino rats.These findings 
support the findings of earlier studies.
CONCLUSION
In the present study, topical phenytoin accelerated healing 
of excisional wound in albino rats.
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